- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Sprint Bioscience AB (SPRINT)
Sprint Bioscience AB stock price live, this page displays ST SPRINT stock exchange data. View the SPRINT premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Sprint Bioscience AB real time stock price chart below.
What Is the Sprint Bioscience AB Stock Price Today?
The Sprint Bioscience AB stock price today is 4.100.
What Is the Stock Symbol for Sprint Bioscience AB?
The stock symbol for Sprint Bioscience AB is "SPRINT."
What Stock Exchange Does Sprint Bioscience AB Trade On?
Sprint Bioscience AB is listed and trades on the Stockholm stock exchange.
Is Sprint Bioscience AB a Good Stock to Buy?
Determining whether Sprint Bioscience AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SPRINT quote. (ISIN: SE0006343745)
What Is the Sprint Bioscience AB Stock Price Today?
The Sprint Bioscience AB stock price today is 4.100.
What Is the Stock Symbol for Sprint Bioscience AB?
The stock symbol for Sprint Bioscience AB is "SPRINT."
What Stock Exchange Does Sprint Bioscience AB Trade On?
Sprint Bioscience AB is listed and trades on the Stockholm stock exchange.
Is Sprint Bioscience AB a Good Stock to Buy?
Determining whether Sprint Bioscience AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SPRINT quote. (ISIN: SE0006343745)
Stockholm
Currency in SEK
4.100
-0.150(-3.53%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.040
4.240
52 wk Range
0.441
4.480
SPRINT is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.0404.240
52 wk Range
0.4414.480
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
SPRINT Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Impressive gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Earnings
Latest Release
May 13, 2026
EPS / Forecast
-0.12 / --
Revenue / Forecast
53K / --
Compare SPRINT to Peers and Sector
Metrics to compare | SPRINT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSPRINTPeersSector | |
|---|---|---|---|---|
P/E Ratio | 5.1x | −3.4x | −0.4x | |
PEG Ratio | 0.01 | −0.15 | 0.00 | |
Price/Book | 4.1x | 4.7x | 2.6x | |
Price / LTM Sales | 2.8x | 10.5x | 3.0x | |
Upside (Analyst Target) | 12.9% | 83.9% | 58.4% | |
Fair Value Upside | Unlock | 15.2% | 8.6% | Unlock |
Sprint Bioscience AB (publ), a pharmaceutical company, engages in the development of drug candidates to treat cancer in Sweden. The company develops VPS34, a drug candidate for the treatment of various types of cancer by using immunotherapies; DCPS which is in preclinical trial for the treatment of acute myeloid leukemia; VRK1, which is in preclinical development to treat solid tumors; VPS34, a drug candidate for the treatment of various types of cancer by using immunotherapies; and NNMT for the treatment of solid tumors/chronic kidney diseases. It is also developing STK25, which is in preclinical trial to treat metabolic liver disease that can lead to inflammation and fibrosis; and TREX1, which is in preclinical trial for the treatment of solid tumors and immuno-oncology. The company has a research collaboration with the Experimental Drug Development Centre for expansion of metabolic dysfunction-associated steatohepatitis programme into inflammatory diseases and evaluation of the STK25 program. The company was incorporated in 2009 and is headquartered in Huddinge, Sweden.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Sprint Bioscience AB (SPRINT) Stock Price Today?
The Sprint Bioscience AB stock price today is 4.100 SEK.
What Stock Exchange Does Sprint Bioscience AB Trade On?
Sprint Bioscience AB is listed and trades on the Stockholm Stock Exchange.
What Is the Stock Symbol for Sprint Bioscience AB?
The stock symbol for Sprint Bioscience AB is "SPRINT."
What Is the Sprint Bioscience AB Market Cap?
As of today, Sprint Bioscience AB market cap is 432.610M SEK.
What Is Sprint Bioscience AB's Earnings Per Share (TTM)?
The Sprint Bioscience AB EPS (TTM) is 0.824.
When Is the Next Sprint Bioscience AB Earnings Date?
Sprint Bioscience AB will release its next earnings report on Aug 26, 2026.
From a Technical Analysis Perspective, Is SPRINT a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Sprint Bioscience AB Stock Split?
Sprint Bioscience AB has split 2 times.
How Many Employees Does Sprint Bioscience AB Have?
Sprint Bioscience AB has 30 employees.
What is the current trading status of Sprint Bioscience AB (SPRINT)?
As of Jun 23, 2026, Sprint Bioscience AB (SPRINT) is trading at a price of 4.100 SEK, with a previous close of 4.250 SEK. The stock has fluctuated within a day range of 4.040 SEK to 4.240 SEK, while its 52-week range spans from 0.441 SEK to 4.480 SEK.
What Is Sprint Bioscience AB (SPRINT) Price Target According to Analysts?
The average 12-month price target for Sprint Bioscience AB is 4.800 SEK, with a high estimate of 4.8 SEK and a low estimate of 4.8 SEK. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +17.07% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.